Our solution is built on proprietary technology developed through years of academic research and trials. Our biomarker method, pioneered by Dr. Shahani, uses specific proteins in the bloodstream as early indicators of breast cancer.
Our innovative approach integrates the strengths of AI and biomarkers to enhance the accuracy of mammogram diagnoses. This method not only improves diagnostic precision but also minimizes false positive results.
Our technology doesn't just save lives; it also reduces the financial burden on the healthcare system. By improving the false positive rate by only 25%, we can save the healthcare system millions
Our technology combines AI and biomarker panels for a comprehensive solution to breast cancer detection. The AI-based approach analyzes mammograms with a 99% accuracy rate, reducing the number of false positives. The biomarker panels provide another layer of precision by using specific proteins in the bloodstream as indicators for breast cancer.
Our Technology
Our AI-based approach uses deep learning to analyze mammograms. Our technology analyzes mammograms with a 99% accuracy rate, significantly reducing the number of false positives. This means we can accurately identify healthy mammograms and those that require further scrutiny by a radiologist.
Our Solution
In addition to our AI-based approach, we use biomarker panels for early detection of breast cancer. Biomarkers are specific proteins in the bloodstream that can be extracted and used as indicators for breast cancer. These biomarkers provide another layer of precision in our diagnostic process, helping to identify breast cancer at its earliest stages.
Our advantage
Our technology enhances the accuracy of mammography screening, enabling early detection of breast cancer. This early detection not only improves patient outcomes but also reduces healthcare costs.
Our AI-based approach to mammogram analysis significantly reduces the number of false positives. This means fewer mammograms require further scrutiny by a radiologist, effectively reducing their workload.
Sein Medical is a medical technology company that specializes in the early detection of breast cancer. We leverage the power of Artificial Intelligence (AI) and biomarker technology to improve the accuracy of mammography screening.
Our technology combines AI and biomarker panels for a comprehensive solution to breast cancer detection. The AI-based approach analyzes mammograms with a 99% accuracy rate, reducing the number of false positives. The biomarker panels provide another layer of precision by using specific proteins in the bloodstream as indicators for breast cancer.
A biomarker panel is a group of specific proteins in the bloodstream that can be extracted and used as indicators for breast cancer. This approach provides another layer of precision in our diagnostic process
Our technology increases the accuracy of mammography screening, allowing for the early detection of breast cancer. Early detection improves patient outcomes and reduces costs on the healthcare system.
Our AI-based approach to mammogram analysis significantly reduces the number of false positives, which in turn reduces the number of mammograms that need further scrutiny by a radiologist. This helps to reduce the workload of radiologists.
You can contact us through our website or via email. We're always here to answer your questions and provide more information about our technology and services.
Copyright©2023 Sein Medical, All rights reserved.